Rush Alzheimer's Disease Center
Rush Alzheimer's Disease Center
The Rush Alzheimer's Disease Center (RADC) is a leading research institution dedicated to the study of Alzheimer's disease and related neurodegenerative disorders. It is part of Rush University Medical Center in Chicago, Illinois. The center is renowned for its comprehensive approach to understanding the causes, progression, and potential treatments for Alzheimer's disease.
History[edit | edit source]
The RADC was established in 1985 as a response to the growing need for research and treatment options for Alzheimer's disease. Over the years, it has become a prominent center for both clinical and basic science research, contributing significantly to the field of neuroscience.
Research Programs[edit | edit source]
The center conducts a wide range of research programs, including:
- Clinical Trials: The RADC participates in numerous clinical trials aimed at testing new treatments and interventions for Alzheimer's disease.
- Epidemiological Studies: These studies focus on understanding the risk factors and prevalence of Alzheimer's disease in different populations.
- Pathophysiology Research: Researchers at the center investigate the biological mechanisms underlying Alzheimer's disease, including the role of amyloid plaques and neurofibrillary tangles.
- Genetic Studies: The RADC explores the genetic components of Alzheimer's disease, identifying genes that may contribute to the risk of developing the condition.
Community Outreach[edit | edit source]
The RADC is committed to community outreach and education. It offers resources and support for patients and families affected by Alzheimer's disease. The center also provides training and education for healthcare professionals to improve the diagnosis and management of the disease.
Collaborations[edit | edit source]
The RADC collaborates with various national and international organizations to advance Alzheimer's research. It is part of the Alzheimer's Disease Centers Program funded by the National Institute on Aging.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
